Tirzepatide (Mounjaro): Commence with 5 mg subcutaneously once weekly, with subsequent weekly titration up to 15 mg or 20 mg, depending on patient response and tolerability
"Medi-Cal Rx Contract Drugs List (CDL) Update: GLP-1 Agonist Coverage Changes Effective January 1, 2026." Wegovy, Zepbound, and Saxenda removed from CDL for weight loss
Ask what happens at renewal, and what continuation criteria apply after the first authorization period
It was actually discovered first
These treatments can be life-changing for overall health, but their success can also bring surprising cosmetic changesespecially to the face
Ethics approval The research was approved by the University of Kufas institutional ethics board (8241/2021) and the Najaf Health Directorate-Training and Human Development Center (Document No.18378/ 2021)